📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RNASEH2B loss and PARP inhibition in advanced prostate cancer. (2024)

First Author: Carmichael J

Attributed to: Sub-clonal RNASH2B/RB1 loss, luminal-to-basal transformation, and novel therapeutic vulnerabilities in metastatic prostate cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci178278

PubMed Identifier: 38833311

Publication URI: http://europepmc.org/abstract/MED/38833311

Type: Journal Article/Review

Volume: 134

Parent Publication: The Journal of clinical investigation

Issue: 21

ISSN: 0021-9738